Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease

Abstract

The disappointments of a series of large anti-amyloid trials have brought home the point that until the driving force behind Alzheimer's disease, and the way it causes harm, are firmly established and accepted, researchers will remain ill-equipped to find Show more